Cargando…
Srf1 Is a Novel Regulator of Phospholipase D Activity and Is Essential to Buffer the Toxic Effects of C16:0 Platelet Activating Factor
During Alzheimer's Disease, sustained exposure to amyloid-β(42) oligomers perturbs metabolism of ether-linked glycerophospholipids defined by a saturated 16 carbon chain at the sn-1 position. The intraneuronal accumulation of 1-O-hexadecyl-2-acetyl-sn-glycerophosphocholine (C16:0 PAF), but not...
Autores principales: | Kennedy, Michael A., Kabbani, Nazir, Lambert, Jean-Philippe, Swayne, Leigh Anne, Ahmed, Fida, Figeys, Daniel, Bennett, Steffany A. L., Bryan, Jennnifer, Baetz, Kristin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037409/ https://www.ncbi.nlm.nih.gov/pubmed/21347278 http://dx.doi.org/10.1371/journal.pgen.1001299 |
Ejemplares similares
-
Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating study
por: Mazereeuw, Graham, et al.
Publicado: (2014) -
Connexins and pannexins in neuronal development and adult neurogenesis
por: Swayne, Leigh Anne, et al.
Publicado: (2016) -
Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study
por: Mazereeuw, Graham, et al.
Publicado: (2015) -
Defining the budding yeast chromatin-associated interactome
por: Lambert, Jean-Philippe, et al.
Publicado: (2010) -
HIE-ISOLDE SRF development activities at CERN
por: Therasse, M, et al.
Publicado: (2011)